Supporting healthcare startups and beyond

Launched in 2012, Cariloop, a certified B Corp and Public Benefit Corporation is now the premier platform for family caregiver support.

We are so proud to have invested in Cariloop when they were still a startup. We took our commitment to assist our portfolio companies to another level when Wendy joined Cariloop full time and served as their Chief Care Officer from 2021 to 2024 after having served on their board for 3 years. In August of 2025, Cariloop was named to Inc. 5000’s list of America’s fastest-growing companies for the 4th year in a row.

Raydiant Oximetry aims to profoundly reduce the rising mortality and morbidity rates among mothers and babies during childbirth by directly measuring fetal oxygen levels with their noninvasive fetal pulse oximeter.

Raydiant’s mission spoke profoundly to Wendy’s background as a pediatrician and the role of which she is most proud, motherhood. We couldn’t be prouder of Raydiant Oximetry as they recently announced a partnership with GE HealthCare.

Take Command Health is the first-to-market leader and #1 HRA (health reimbursement arrangement) administration platform in the country. 

Serving over 7,000 leading organizations, they are on a mission to create a consumer-centric healthcare system. We are seriously on board with that mission and have every confidence in Take Command’s team.

SIA, acquired by Integra Life Sciences in 2023, is one of several successful surgical device companies that Fred has helped and one that achieved a successful exit. 

SIA developed a polydioxanone mesh (Durasorb®️) that facilitates implant support and positioning in reconstructive and cosmetic breast surgery and gradually resorbs over time so there are less issues long term. Fred will be presenting his series of patients at the American Society of Plastic Surgeons meeting in New Orleans in October 2025.  He also hopes to assist Integra’s work with the FDA to get Durasorb to be the first FDA approved mesh for use in breast surgery after PMA (pre-market approval) has been obtained.

Puzzle Medical Devices® Inc. is a Canadian company specializing in the development of a minimally invasive long-term hemodynamic transcatheter pump.

Led by Jade Doucet-Martineau, this woman-led organization is a rock star in our portfolio. They recently raised a $43M series A round. This raise represents one of the largest medical device raises in the past two years in Canada.

Modality.AI redefines how neurological and psychiatric conditions are assessed in clinical research.

They have built a reliable, science-first, multimodal assessment platform that turns structured conversations into precise measures of speech, facial expression, and motor function—without requiring a clinic visit, dedicated device, or clinical rater. Modality leads our portfolio, and stands out among all startups, with its impressive list of published scientific papers.

Access Vascular is solving the greatest challenges in vascular access.

They offer a suite of vascular access devices that use their novel, patented biomaterial featuring MIMIX® technology which is designed to prevent the most common and costly complications in vascular access. Vascular access is a critical component of healthcare with vascular access device (VAD) use essential in healthcare settings around the world.